Cara Therapeutics Announces Positive Results From Phase 2 Trial in Uremic Pruritus
July 23, 2015 at 07:06 AM EDT
Cara Therapeutics, Inc. (Nasdaq: CARA) today announced statistically significant topline results from its Phase 2 trial of its lead ...
